The Perils of Pain Meds Revisited
Phase 2 Results for Mavrilimumab Are In
Turmeric: The Evidence for Therapeutic Use for Arthritis
FDA Issues Safety Warning
HCQ Debate: Should Dose Be No More Than 5 mg/kg in All SLE Patients?
A Comprehensive Review of NSAID Cardiovascular Toxicity
Hydroxychloroquine Risk-Benefit Discussion, & a Handy Dosage App
Drug Safety: Fasinumab Evaluated in Clinical Trials, Plus Celecoxib May Not Pose Increased Heart Attack or Stroke Risk
FDA Staff Raises Safety Concerns Over Arthritis Drug Baricitinib
- 1
- 2
- 3
- …
- 16
- Next Page »